- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06424535
Integrated Traditional Chinese and Western Medicine to Care for the Late Stage of Mild to Moderate Burns and Scalds
Study Overview
Status
Conditions
Detailed Description
Burns are an irreversible traumatic injury. When the skin suffers severe burns, it will cause a systemic shock to the individual. Although in recent years, with the advancement of medical technology, the mortality rate from burns and scalds has dropped significantly compared with the past, patients with burns and scalds also face many challenges during the treatment process, including having to endure the pain of the wound and the risk of infection during hospitalization. During the rehabilitation period after discharge, scarring, limb contracture, skin itching and appearance changes caused by burns and scalds will cause a significant decline in the patient's quality of life and lead to depression, withdrawal, social isolation and other phenomena. Traditional Chinese medicine is based on empirical medicine and the observation records of doctors. It has been passed down from generation to generation, and also have experience in treating fever. There are external and internal treatments for treating burns and scalds. External medicinal powders and ointments, such as Sanhuang powder,Jinchuang ointment,Ziyun ointment, etc. For internal medicine,Huanglian Jiedu Decoction,Qingying Decoction,Xijiao Dihuang Decoction,Tuoli Disinfection Powder,Shenling Baizhu Powder, etc. can be used according to different syndrome types. In addition, past studies have also confirmed that acupuncture can relieve burns and scalds and inhibit scar formation. Acupuncture can also improve gastrointestinal function and can be used to maintain good nutrient absorption in patients during the treatment of burns and scalds.
There are few large-scale studies on the joint treatment of burns and scalds between Chinese and Western medicine. Therefore, the purpose of this project is to compare the wound healing status and healing time between two groups that simply received conventional Western medicine treatment and conventional treatment plus interventional treatment with Chinese medicine. The study investigate traditional Chinese medicine interventional treatment model for mild to moderate burns and scalds, and hope to implement it clinically in the future to improve medical quality and treatment efficiency.
A single-center, randomized control crossover trial. This study will be conducted at the Burn and Scald Center and Plastic Surgery/Traditional Chinese Medicine Clinic of China Medical University Hospital. When patients seek medical treatment for burns and scalds, they will be evaluated by a plastic surgeon and randomly assigned into two groups. One group will receive conventional Western medicine treatment plus TCM intervention. Different treatment strategies will be adopted depending on the severity of the condition, and the first assessment will be conducted before TCM interventional treatment. , a post-test was conducted four weeks after treatment. Afterward, the two groups will be alternated. The group that did not receive TCM intervention received TCM interventional treatment for four weeks, while the other group received only conventional Western medicine treatment. The assessment items included: assessment of wound and pain status. Pain status was assessed using the Visual Analogue Scale (VAS), and scars were assessed using the Vancouver Scar Scale (VSS). Assess, and record critical indicators according to clinical needs, such as caloric requirement (kcal), daily fluid requirement (ml), daily urine output (ml) and other physiological parameters, and record the burn area (Modified Lund-Browder chart) and depth. The control group will be treated with conventional Western medicine. Outcome measurements will be assessed at baseline, 4 weeks, and 4 weeks after crossover (8 weeks). The goal of our study is to measure the effectiveness of TCM interventional treatment in shortening recovery time and improving accompanying symptoms of burns and scalds.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taichung, Taiwan, 403
- China Medical University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age:20-90.
- Patients with mild to moderate injuries and burns that meet the American Burn Association (ABA) injury classification.
Exclusion Criteria:
- Patients refuse TCM intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention group
|
The treatment project a Chinese medicine practitioner based individual needs of the patient, and will be followed by a four-week treatment.
Other Names:
|
|
Active Comparator: control group
Routine Western medicine burn and scald care prescribed by department doctor
|
Patients will receive routine Western medicine treatments as per individual patient's needs.
The medications and bandages can vary due to the depth and size of the burn and scald.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analogue Scale
Time Frame: At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
Measured by the Visual Analogue Scale (VAS) 0-10: 0 =No Pain 2 = Mild 4 = Nagging 6 =Miserable 8 =Intense 10 = Worst
|
At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
|
Vancouver Scar Scale
Time Frame: At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
Scars measurement will be assessed using the Vancouver Scar Scale (VSS)Each characteristic is given a score, which are added together to give an overall score between 0 and 13.
Higher score indicate wrost outcome.
|
At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caloric intake per day
Time Frame: At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
Amount of caloric (kcal) consumed per patient per day measured by department's nurse calculated by the amount of calories the patient consumed via feeding tube or oral feeding
|
At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
|
Daily fluid requirement (ml)
Time Frame: At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
Amount of daily fluid requirement (ml) per patient per day measured by department's nurse in milliliters (ml) of fluid intake and intravenous infusion or oral intake.
|
At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
|
Daily urine output
Time Frame: At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
Amount of Daily urine output measured by department's nurse in milliliters(ml) per patient patients Daily urine output measured by department's nurse in milliliters(ml) per day
|
At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
|
Lund-Browder chart
Time Frame: At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
burn area measured by Modified Lund-Browder chart, the score represents percentage (%) of the body cover by the burn along with body area, it score 0-100 and a higher score indicate worst outcome
|
At baseline, 4 weeks, and 4 weeks after crossover (8 weeks)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CMUH113-REC1-055
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burns and Scalds
-
London School of Hygiene and Tropical MedicineCamden Primary Care Trust, London; London Borough of Camden Housing and Adult...CompletedHot Water Burns (Scalds)United Kingdom
-
Advanced Medical Solutions Ltd.RecruitingSurgical Wounds | Venous Leg Ulcer | Pressure Ulcer | Diabetic Ulcers | Arterial Leg Ulcer | Traumatic Wounds | Postoperative Wound Healing | Burns and ScaldsSpain
-
Lohmann & RauscherAXCELLANTRecruitingSurgical Wounds | Pressure Ulcers | Venous Ulcers | Arterial Ulcers | Diabetic Ulcers | Epidermolysis Bullosa (EB) | Traumatic Wounds | Burns and Scalds | Postoperative Wounds Healing by Secondary IntentionPoland
-
Fondation Ophtalmologique Adolphe de RothschildNot yet recruiting
-
American Scitech InternationalJohnson & JohnsonUnknownBurns | Electric BurnsUnited States
-
MediWound LtdUnknownBurns, Upper Extremity | Burns, Lower ExtremitySlovakia
-
Singapore General HospitalUnknownAcute Thermal BurnsSingapore
-
RenovaCare, IncActive, not recruitingBurns | Burns Second Degree | Burns Deep Second DegreeUnited States
-
Sun Yat-sen UniversityCompleted
-
Hennepin Healthcare Research InstituteNot yet recruiting
Clinical Trials on Chinese medicine for internal or external use、Acupuncture or Laser acupuncture pen treatment、Acupoint Tuina massage、Acupoint application of traditional Chinese herbal medicinal cake
-
China Medical University HospitalRecruitingCritically Ill PatientsTaiwan